Review



cd18  (Developmental Studies Hybridoma Bank)


Bioz Verified Symbol Developmental Studies Hybridoma Bank is a verified supplier
Bioz Manufacturer Symbol Developmental Studies Hybridoma Bank manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Developmental Studies Hybridoma Bank cd18
    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and <t>CD11a/CD18</t> LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Cd18, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 91/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd18/product/Developmental Studies Hybridoma Bank
    Average 91 stars, based on 16 article reviews
    cd18 - by Bioz Stars, 2026-05
    91/100 stars

    Images

    1) Product Images from "Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV‑1 Isolation from Limited Plasma Volumes"

    Article Title: Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV‑1 Isolation from Limited Plasma Volumes

    Journal: Analytical Chemistry

    doi: 10.1021/acs.analchem.5c06176

    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and CD11a/CD18 LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Figure Legend Snippet: Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and CD11a/CD18 LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).

    Techniques Used: Incubation, Clinical Proteomics, Negative Control, Control, Quantitative RT-PCR



    Similar Products

    cd18  (Developmental Studies Hybridoma Bank)
    91
    Developmental Studies Hybridoma Bank cd18
    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and <t>CD11a/CD18</t> LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Cd18, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd18/product/Developmental Studies Hybridoma Bank
    Average 91 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-05
    91/100 stars
    		  Buy from Supplier
    itgb2 cd18 agonist leukadherin 1  (MedChemExpress)
    92
    MedChemExpress itgb2 cd18 agonist leukadherin 1
    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and <t>CD11a/CD18</t> LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Itgb2 Cd18 Agonist Leukadherin 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/itgb2 cd18 agonist leukadherin 1/product/MedChemExpress
    Average 92 stars, based on 1 article reviews
    itgb2 cd18 agonist leukadherin 1 - by Bioz Stars, 2026-05
    92/100 stars
    		  Buy from Supplier
    ○ cd18 mouse anti dog  (Bio-Rad)
    93
    Bio-Rad ○ cd18 mouse anti dog
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    ○ Cd18 Mouse Anti Dog, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/○ cd18 mouse anti dog/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    ○ cd18 mouse anti dog - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    cd18 ß2 integrin r d systems fab1730r 100ug  (R&D Systems)
    94
    R&D Systems cd18 ß2 integrin r d systems fab1730r 100ug
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    Cd18 ß2 Integrin R D Systems Fab1730r 100ug, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd18 ß2 integrin r d systems fab1730r 100ug/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    cd18 ß2 integrin r d systems fab1730r 100ug - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cd18  (Proteintech)
    94
    Proteintech cd18
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    Cd18, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd18/product/Proteintech
    Average 94 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    anti integrin blocking β2 cd18 antibody  (Merck & Co)
    86
    Merck & Co anti integrin blocking β2 cd18 antibody
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    Anti Integrin Blocking β2 Cd18 Antibody, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti integrin blocking β2 cd18 antibody/product/Merck & Co
    Average 86 stars, based on 1 article reviews
    anti integrin blocking β2 cd18 antibody - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    o cd18 mouse anti dog  (Bio-Rad)
    93
    Bio-Rad o cd18 mouse anti dog
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    O Cd18 Mouse Anti Dog, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/o cd18 mouse anti dog/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    o cd18 mouse anti dog - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    rea1112  (Miltenyi Biotec)
    90
    Miltenyi Biotec rea1112
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    Rea1112, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rea1112/product/Miltenyi Biotec
    Average 90 stars, based on 1 article reviews
    rea1112 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    cd18  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc cd18
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    Cd18, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd18/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and CD11a/CD18 LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).

    Journal: Analytical Chemistry

    Article Title: Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV‑1 Isolation from Limited Plasma Volumes

    doi: 10.1021/acs.analchem.5c06176

    Figure Lengend Snippet: Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and CD11a/CD18 LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).

    Article Snippet: Mouse IgG antibodies: CD8 (UCH-T4), Cat # sc-1181, Santa Cruz Biotechnology, Inc.; CD18 (Integrin beta-2), Clone ID H52-s, DSHB (Developmental Studies Hybridoma Bank); HIV1gp120, Cat # sc-57810, Santa Cruz Biotechnology, Inc.; CD26, Cat # 555435, BD Pharmingen; integrin alpha-4, Clone ID P4G9, DSHB; CD43 (DF-T1), Cat # sc-6256, Santa Cruz Biotechnology, Inc.; CD46 (1E3D1), Cat # MA5-29113, Invitrogen; β 2 -microglobulin (B2M-01), Cat # MA1–19141, Invitrogen; integrin alpha-L (CD11a), Clone ID MHM.24, DSHB; CD86 (B7-2), Clone ID IT2.2, Invitrogen; CD44, Clone ID H4C4, DSHB; ICAM1, Clone ID P2A4, DSHB; CD45, Clone ID H5A5, DSHB; HLA-DR, Clone ID LN3, Cat # 14-9956-82, Thermo Fisher Scientific; Tim-4 (human):Fc (mouse) (rec.), Cat # CHI-HF-211T4-C100, AdipoGen Life Sciences.

    Techniques: Incubation, Clinical Proteomics, Negative Control, Control, Quantitative RT-PCR

    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for CD18, CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.

    Journal: MethodsX

    Article Title: Feline leukocyte immunophenotyping: an optimised whole-blood flow cytometry protocol

    doi: 10.1016/j.mex.2026.103869

    Figure Lengend Snippet: Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for CD18, CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.

    Article Snippet: Step 2 – Leukocytes extracellular staining Materials • EDTA Whole blood sample ± Transfix® • 200 μl pipettes • 100 μl pipettes • 10 μl pipettes • Flow cytometry tubes • Permanent marker • Cytometer tube rack Reagents • Monoclonal antibodies: ○ CD5 Anti-cat – clone FE1.1B11 (BIO-RAD®) ○ CD4 Anti-cat – clone vpg34 (BIO-RAD®) ○ CD8 Anti-cat alpha/beta purified – clone vpg9 (BIO-RAD®) ○ Rat Anti-Mouse IgG1 – clone X56 (BIO-RAD®) ○ CD18 Mouse Anti-Dog – clone CA1.4E9 (BIO-RAD®) ○ CD21 Mouse Anti-Dog – clone CA2.1D6 (BIO-RAD®) ○ CD45R Rat Anti-Mouse – clone RA3–6B2 (BIO-RAD®) • 10x Red blood cells (RBC) lysis buffer solution (BD FACSTM lysing solution) • PBS 1% solution Equipment • Countess TM 3 (Thermo Fisher Scientific, USA) • Freezer • Dark incubation chamber • Timer • Vortex (MX-S®, China) • Centrifuge (model 5810R, Eppendorf®, Germany) • Flow cytometry analyser BD FACSCanto II (Becton Dickinson (BD), San Jose, USA) Methods 1.

    Techniques: Titration, Bioprocessing